SpringWorks Therapeutics Net Income
The Net Income of SpringWorks Therapeutics (SWTX) as of Oct 28, 2026 is -258.13 M USD. In the previous year, Net Income was -325.10 M USD — a change of -20.60% (higher).
Get this data via API
Financial Data API
Net Income
-258.13 MUSD
YoY
-20.60%
Last updated:
In 2024, SpringWorks Therapeutics's profit amounted to -258.13 M USD, a -20.60% increase from the -325.10 M USD profit recorded in the previous year.
The SpringWorks Therapeutics Net Income history
3 Years
10 Years
25 Years
Max
| YEAR | Net Income | YoY |
|---|---|---|
| est | 118.25 MUSD | -59.74% |
| est | 293.75 MUSD | +126.31% |
| est | 129.80 MUSD | -308.79% |
| est | -62.17 MUSD | -69.98% |
| est | -207.09 MUSD | -19.77% |
| -258.13 MUSD | -20.60% | |
| -325.10 MUSD | +18.58% | |
| -274.16 MUSD | +58.28% | |
| -173.21 MUSD | +291.49% | |
| -44.24 MUSD | -19.20% | |
| -54.76 MUSD | +207.41% | |
| -17.81 MUSD | +283.98% | |
| -4.64 MUSD | -145.79% | |
| 10.13 MUSD | +78.87% | |
| 5.66 MUSD | +9.18% | |
| 5.19 MUSD | +45.85% | |
| 3.56 MUSD | +7.14% | |
| 3.32 MUSD | -28.37% | |
| 4.64 MUSD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
SpringWorks Therapeutics Revenue
SpringWorks Therapeutics Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
SpringWorks Therapeutics Margins
SpringWorks Therapeutics stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
SpringWorks Therapeutics Stock analysis
Net Income Details
Understanding SpringWorks Therapeutics's Profit Margins
The profit margins of SpringWorks Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of SpringWorks Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating SpringWorks Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
SpringWorks Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When SpringWorks Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about SpringWorks Therapeutics stock
Net Income of SpringWorks Therapeutics is -258.13 M USD in 2024.
Net Income of SpringWorks Therapeutics changed from -325.10 M USD to -258.13 M USD, representing a -20.60% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Net Income SpringWorks Therapeutics since 2006 – with annual values, charts, and detailed analysis.
The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.
The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.
Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's SpringWorks Therapeutics historically and in real time.
The profit in evaluating a stock
History, usage, calculation, and application of earnings in securities trading.
The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.
Use of Profits
In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.
Calculation of profits
There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.
Use of profits
There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.
Advantages and disadvantages of using profits
There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.
However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.
t('components_kpi_Explanation_34')
Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — SpringWorks Therapeutics
All Key Metrics — SpringWorks Therapeutics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth